This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 1994 Apr;57(4):401-3.

doi: 10.1136/jnnp.57.4.401.

Drug treatment of Parkinson's disease: is "polypharmacy" best?

Affiliations

PMID: 8163984
PMCID: PMC1072864
DOI: 10.1136/jnnp.57.4.401

Review

Drug treatment of Parkinson's disease: is "polypharmacy" best?

P D Swanson. J Neurol Neurosurg Psychiatry. 1994 Apr.

. 1994 Apr;57(4):401-3.

doi: 10.1136/jnnp.57.4.401.

Author

Affiliation

¹ Division of Neurology, University of Washington School of Medicine, Seattle 98195.

PMID: 8163984
PMCID: PMC1072864
DOI: 10.1136/jnnp.57.4.401

No abstract available

PubMed Disclaimer

Similar articles

New treatment for people with Parkinson's.
[No authors listed] [No authors listed] FDA Consum. 2004 Jul-Aug;38(4):5. FDA Consum. 2004. PMID: 15346564 No abstract available.
Drugs for Parkinson's Disease.
[No authors listed] [No authors listed] Treat Guidel Med Lett. 2004 Jun;2(22):41-6. Treat Guidel Med Lett. 2004. PMID: 15529113 Review. No abstract available.
[Dangers in drug therapy of Parkinson's disease].
Gehlen W. Gehlen W. Z Allgemeinmed. 1975 Nov 30;51(33):1543-4. Z Allgemeinmed. 1975. PMID: 1210361 German. No abstract available.
Treatments for Parkinson's disease.
[No authors listed] [No authors listed] Health News. 2000 Jun;6(6):8. Health News. 2000. PMID: 10865523 No abstract available.
[ What drug strategies are advisable for patients with advanced-stage Parkinson's].
Brefel-Courbon C. Brefel-Courbon C. Rev Neurol (Paris). 2000;156 Suppl 2 Pt 2:120-59. Rev Neurol (Paris). 2000. PMID: 10916046 Review. French. No abstract available.

See all similar articles

Cited by

Safety and Tolerability of Pharmacotherapies for Parkinson's Disease in Geriatric Patients.
Klietz M, Greten S, Wegner F, Höglinger GU. Klietz M, et al. Drugs Aging. 2019 Jun;36(6):511-530. doi: 10.1007/s40266-019-00654-z. Drugs Aging. 2019. PMID: 30937878 Review.
Drug treatment of Parkinson's disease.
Quinn N. Quinn N. BMJ. 1995 Mar 4;310(6979):575-9. doi: 10.1136/bmj.310.6979.575. BMJ. 1995. PMID: 7888935 Free PMC article. Review.
Idiopathic Parkinson's disease: epidemiology, diagnosis and management.
Ben-Shlomo Y, Sieradzan K. Ben-Shlomo Y, et al. Br J Gen Pract. 1995 May;45(394):261-8. Br J Gen Pract. 1995. PMID: 7619574 Free PMC article. Review.

References

1. Eur Neurol. 1988;28 Suppl 1:3-8 - PubMed
1. Ann Neurol. 1987 Jul;22(1):8-12 - PubMed
1. Mov Disord. 1986;1(1):65-8 - PubMed
1. Science. 1989 Aug 4;245(4917):519-22 - PubMed
1. Arch Neurol. 1989 Dec;46(12):1275-9 - PubMed

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
Medical
- MedlinePlus Health Information